M. Ahsan Chaudhry

High Busulfan Exposure Is Associated with Worse Outcomes in a Daily i.v. Busulfan and Fludarabine Allogeneic Transplant Regimen

Michelle Geddes, Shahbal B. Kangarloo, Naveed Farrukh et al. · Biology of Blood and Marrow Transplantation · 2008 · 148 citations · Full text

Medicine, Hematology, Pharmacology +17

Outcomes following HSCT Using Fludarabine, Busulfan, and Thymoglobulin: A Matched Comparison to Allogeneic Transplants Conditioned with Busulfan and Cyclophosphamide

Christopher Bredeson, Mei‐Jie Zhang, Afiba Manza‐A. Agovi et al. · Biology of Blood and Marrow Transplantation · 2008 · 87 citations · Full text

Medicine, Hematology, Immunology +16

Allogeneic Transplantation for Adult Acute Leukemia in First and Second Remission with a Novel Regimen Incorporating Daily Intravenous Busulfan, Fludarabine, 400 CGY Total-Body Irradiation, and Thymoglobulin

James A. Russell, Mary Lynn Savoie, A. Balogh et al. · Biology of Blood and Marrow Transplantation · 2007 · 79 citations · Full text

Medicine, Immunology, Oncology +13

The Addition of 400 cGY Total Body Irradiation to a Regimen Incorporating Once-Daily Intravenous Busulfan, Fludarabine, and Antithymocyte Globulin Reduces Relapse Without Affecting Nonrelapse Mortality in Acute Myelogenous Leukemia

James A. Russell, William Irish, A. Balogh et al. · Biology of Blood and Marrow Transplantation · 2009 · 59 citations · Full text

Medicine, Hematology, Pharmacology +15

Transplantation from Matched Siblings Using Once-Daily Intravenous Busulfan/Fludarabine with Thymoglobulin: A Myeloablative Regimen with Low Nonrelapse Mortality in All But Older Patients with High-Risk Disease

James A. Russell, Qiuli Duan, M. Ahsan Chaudhry et al. · Biology of Blood and Marrow Transplantation · 2008 · 49 citations · Full text

Medicine, Hematology, Immunology +15